Trials / Completed
CompletedNCT01212601
Collect Clinical Data in Chinese Patients Received CUBICIN Treatment for Actual Usage in Clinical Practice
A Multicenter, Observational, Non-interventional Registry Designed to Collect Clinical Data in Chinese Patients Who Have Received CUBICIN® Treatment Under Condition of Actual Usage in Clinical Practice
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 203 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This is a Multicenter, observational, non-interventional registry designed to collect clinical data in Chinese patients who have received CUBICIN treatment under condition of actual usage in clinical practice.
Detailed description
MC MD
Conditions
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2012-11-01
- Completion
- 2012-11-01
- First posted
- 2010-09-30
- Last updated
- 2012-11-27
Locations
18 sites across 1 country: China
Source: ClinicalTrials.gov record NCT01212601. Inclusion in this directory is not an endorsement.